NeuroMetrix Inc. (NURO) Fundamentals

NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment of being Medical equipment and consumables.
SHARE INFORMATION
Market Cap$ 12,721,851
Shares Outstanding7,757,226
Float7,710,583
Percent Float99.4%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 8,253,493
Latest Fiscal EPS$ -0.44
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions34
Institutional Holdings Date2022-10-31
Institutional Bought Previous 3 Months114,946
Institutional Holdings Percent19.5%
Institutional Sold Previous 3 Months26,816
Insider Holdings Date2022-10-31
Insider Bought Previous 3 Months-
Insider Holdings Percent12.4
Insider Sold Previous 3 Months-
Insider Shares Owned962,886
TRADING INFO
52 Week High$ 7.53
52 Week Low$ 1.35
52 Week High Change$ -77.06
21 Day Moving Average$ 1.6431
21 Day Extended Moving Average$ 1.7131
50 Day Moving Average$ 2.0987
50 Day Extended Moving Average$ 2.0772
200 Day Moving Average$ 3.3313
200 Day Extended Moving Average$ 3.3914
10 Day Average Volume30,459
20 Day Average Volume689,750
30 Day Average Volume498,497
50 Day Average Volume678,845
Alpha0.002611
Beta2.2821
Standard Deviation0.510696
R20.055979
7 Day Price Change$ 0.06
7 Day Percent Change3.8%
21 Day Price Change$ -0.03
21 Day Percent Change-1.8%
30 Day Price Change$ -0.11
30 Day Percent Change-6.29%
Month to Date Price Change$ -0.02
Month to Date Percent Change-1.2%
Quarter to Date Price Change$ -1.15
Quarter to Date Percent Change-41.22%
180 Day Price Change$ -2.46
180 Day Percent Change-60.0%
200 Day Price Change$ -1.51
200 Day Percent Change-47.94%
Year to Date Price Change$ -3.38
Year to Date Percent Change-67.33%

NeuroMetrix Inc. (NURO) Key Ratios

PROFITABILITY
EBIT Margin-59.4%
EBITDA Margin-59.3%
Pre-Tax Profit Margin-39.8%
Profit Margin Count-57.66%
Gross Margin70.0%
Profit Margin TOT-57.66%
INCOME STATEMENTS
Revenue$ 8,228,858
Revenue Per Share$ 1.0608
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.60
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio12.80
Leverage Ratio1.10
Quick Ratio11.70
Long Term Debt To Capital0.01
VALUATION MEASURES
PE Ratio-2.20
Enterprise Value$ -8,110,585
Price to Sales1.546
Price to Free Cash-2.80
PE High Last 5 Years690.00
Price To Book0.60
Price To Cash Flow2.80
PE Low Last 5 Years-3.00
Price to Tangible Book0.60
MANAGEMENT EFFECTIVENESS
Receivables Turnover15.80
Invoice Turnover2.60
Assets Turnover0.50
Return Assets-20.42
Return on Equity-22.25
Return on Capital-20.01

NeuroMetrix Inc. (NURO) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorBaker Tilly US LLP
CEOShai N. Gozani
Emplyoees23
Last AuditUQ
CIK0001289850
IndustryMedical Devices & Instruments
SectorHealthcare
NAICSSurgical and Medical Instrument Manufacturing(339112)
CONTACT INFO
Address4B Gill Street
Woburn, MA 1801
Websitehttps://www.neurometrix.com
Facsimile-
Telephone+1 781 890-9989
EmailNEUROMetrix.IR@NEUROMetrix.com


Your Recent History
NASDAQ
NURO
NeuroMetri..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.